Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
Asıl Yazarlar: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Frontiers Media
2024
|
Benzer Materyaller
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Yazar:: Grace A. Borchert, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
Yazar:: Grace A. Borchert, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
Yazar:: Michelle E. McClements, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
Yazar:: Borchert, GA, ve diğerleri
Baskı/Yayın Bilgisi: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
Yazar:: Hoda Shamsnajafabadi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)